“Solubilisation of a strongly aggregated vaccine antigen”, a research project performed for Sanofi Pasteur (France).
In this case study, Synthelis was required to evaluate the capability of the cell-free technology to express the antigen of interest and avoid the formation of inclusion bodies. We were then able to demonstrate that cell-free system is a powerful alternative to circumvent precipitate issues, which come frequently across vaccine antigen production. To access the full case study, please click here.
Feel free to contact us for more information.